Focusing on breast cancer, concerning increased fatty acid (FA) synthesis, the limiting enzyme is fatty acid synthase (FAS), encoded by the FASN gene, which is known to have oncogenic functions [61]. This evidence concerns the gene FAS and breast carcinoma.